共 171 条
[1]
Blay JY(2021)Gastrointestinal stromal tumours Nat Rev Dis Primers 7 22-580
[2]
Kang YK(1998)Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors Science (New York, NY) 279 577-710
[3]
Nishida T(2003)PDGFRA activating mutations in gastrointestinal stromal tumors Science (New York, NY) 299 708-5202
[4]
von Mehren M(2018)Chinese consensus on management of tyrosine kinase inhibitor-associated side effects in gastrointestinal stromal tumors World J Gastroenterol 24 5189-323
[5]
Hirota S(2019)Cytoreductive surgery for metastatic gastrointestinal stromal tumors followed by sunitinib compared to followed by imatinib-a multi-center cohort study Eur J Surg Oncol 45 318-761
[6]
Isozaki K(2022)Gastrointestinal stromal tumors: what is the best sequence of TKIs? Curr Treat Options Oncol 23 749-215
[7]
Moriyama Y(2021)Dual EGFR-VEGF pathway inhibition: a promising strategy for patients with EGFR-mutant NSCLC J Thorac Oncol 16 205-33
[8]
Heinrich MC(2022)Gastrointestinal stromal tumours: ESMO-EURACAN-GENTURIS clinical practice guidelines for diagnosis, treatment and follow-up Ann Oncol 33 20-5359
[9]
Corless CL(2008)Primary and secondary kinase genotypes correlate with the biological and clinical activity of sunitinib in imatinib-resistant gastrointestinal stromal tumor J Clinic Oncol : Official J Am Soc Clinic Oncol 26 5352-1104
[10]
Duensing A(2009)Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial Lancet (London, England) 373 1097-1069